Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Platelets

• Publication date

  2018-11-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/09537104.2017.1416076PMID 29265902PMCID PMC6185807
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potentiation of TRAP-6-induced platelet dense granule release by blockade of P2Y12 signaling with MRS2395

  2018cited by this paper
• Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug

  2018cited by this paper
• Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival

  2017cited by this paper
• ASK1 facilitates tumor metastasis through phosphorylation of an ADP receptor P2Y12 in platelets

  2017cited by this paper
• Platelets subvert T cell immunity against cancer via GARP-TGFβ axis

  2017cited by this paper
• Role of ADP receptors on platelets in the growth of ovarian cancer.

  2017cited by this paper
• Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation

  2017cited by this paper
• Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.

  2017cited by this paper
• Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation: Implications for the oncoprotein c-MYC.

  2017cited by this paper
• Platelet releasate promotes breast cancer growth and angiogenesis via VEGF–integrin cooperative signalling

  2017cited by this paper
• A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis

  2017cited by this paper
• Ticagrelor breaks up the tumor-platelet party.

  2017cited by this paper
• Platelet releasates promote the proliferation of hepatocellular carcinoma cells by suppressing the expression of KLF6

  2017cited by this paper
• Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study

  2017cited by this paper
• Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.

  2016cited by this paper
• Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1

  2016cited by this paper
• Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer

  2016cited by this paper
• Recent trends in the prevalence of low-dose aspirin use for primary and secondary prevention of cardiovascular disease in the United States, 2012–2015☆

  2016cited by this paper
• Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies

  2016cited by this paper
• Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force

  2016cited by this paper
• Aspirin and Cancer.

  2016cited by this paper
• The prothrombotic activity of cancer cells in the circulation.

  2016cited by this paper
• PF4 Promotes Platelet Production and Lung Cancer Growth.

  2016cited by this paper
• Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process

  2015cited by this paper
• P-selectin-mediated platelet adhesion promotes tumor growth

  2015cited by this paper
• Aspirin and prostate cancer prevention

  2015cited by this paper
• Molecular Pathways: Aspirin and Wnt Signaling—A Molecularly Targeted Approach to Cancer Prevention and Treatment

  2014cited by this paper
• Aspirin and prostate cancer prevention.

  2014cited by this paper
• A novel and essential role for FcγRIIa in cancer cell-induced platelet activation.

  2014cited by this paper
• Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial.

  2013cited by this paper
• Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial

  2013cited by this paper
• Platelet‐mediated angiogenesis is independent of VEGF and fully inhibited by aspirin

  2013cited by this paper
• Thrombocytosis has a negative prognostic value in lung cancer.

  2013cited by this paper
• Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

  2012cited by this paper
• Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis.

  2012cited by this paper
• Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer

  2012cited by this paper
• Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

  2012cited by this paper
• Paraneoplastic thrombocytosis in ovarian cancer.

  2012influential reference
• Platelets increase the proliferation of ovarian cancer cells.

  2012cited by this paper
• The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination.

  2012cited by this paper
• Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

  2011cited by this paper
• A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing.

  2011cited by this paper
• Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis.

  2011cited by this paper
• Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis.

  2011cited by this paper
• Comparison of tumor and microenvironment secretomes in plasma and in platelets during prostate cancer growth in a xenograft model.

  2010cited by this paper
• Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.

  2010cited by this paper
• Platelets actively sequester angiogenesis regulators.

  2009cited by this paper
• Role of platelet-derived microparticles in angiogenesis and tumor progression.

  2009cited by this paper
• Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.

  2009cited by this paper
• Platelet‐derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP‐2 production

  2009cited by this paper
• Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study. 1988.

  2007cited by this paper
• Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement

  2007cited by this paper
• Acetylsalicylic acid is compounding to antiplatelet effect of C-reactive protein.

  2007cited by this paper
• Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer

  2007cited by this paper
• Involvement of the Snake Toxin Receptor CLEC-2, in Podoplanin-mediated Platelet Activation, by Cancer Cells*♦

  2007cited by this paper
• Celecoxib for the prevention of colorectal adenomatous polyps.

  2006cited by this paper
• Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.

  2006cited by this paper
• Prognostic value of thrombocytosis in renal cell carcinoma.

  2006cited by this paper
• Enhancing effect of platelet‐derived microvesicles on the invasive potential of breast cancer cells

  2006cited by this paper
• Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.

  2005cited by this paper
• Efficacy and safety of low-dose aspirin in polycythemia vera.

  2004cited by this paper
• The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease

  2004cited by this paper
• Impact of pretreatment thrombocytosis on survival in primary breast cancer

  2003cited by this paper
• A randomized trial of aspirin to prevent colorectal adenomas.

  2003cited by this paper
• A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

  2003cited by this paper
• Aspirin and the prevention of colorectal cancer.

  2003cited by this paper
• Aspirin and the prevention of colorectal cancer.

  2003cited by this paper
• Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells.

  2002cited by this paper
• Cell-cell interactions in inflammation and cancer metastasis

  2001cited by this paper
• Aspirin and risk for gastric cancer: a population-based case–control study in Sweden

  2001cited by this paper
• Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions.

  2000cited by this paper
• Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis.

  1999cited by this paper
• Prognostic significance of thrombocytosis in patients with primary lung cancer.

  1996cited by this paper
• Aspirin and cancer.

  1995influential reference
• Low-dose aspirin and incidence of colorectal tumors in a randomized trial.

  1993cited by this paper
• Aspirin use and reduced risk of fatal colon cancer.

  1991cited by this paper
• Aspirin use and chronic diseases: a cohort study of the elderly.

  1989cited by this paper
• Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study.

  1988cited by this paper
• The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat.

  1983cited by this paper
• Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment.

  1981cited by this paper
• Platelets as a source of growth-promoting factor(s) for tumor cells.

  1980cited by this paper
• Thrombocytosis: platelet kinetics in neoplasia.

  1974cited by this paper
• Antimetastatic effects associated with platelet reduction.

  1968cited by this paper
• THROMBOCYTOSIS ASSOCIATED WITH MALIGNANT DISEASE.

  1964cited by this paper

• Mechanism-Oriented Treatment of Early Neurologic Deterioration in Acute Ischemic Stroke

  2026cites this paper
• Cancer-Associated Stroke: Thrombosis Mechanism, Diagnosis, Outcome, and Therapeutic Strategies

  2024cites this paper
• Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis

  2022cites this paper
• Emerging roles of platelets in cancer biology and their potential as therapeutic targets

  2022cites this paper
• Aspirin and antiplatelet treatments in cancer

  2021cites this paper
• Advances in Intracellular Calcium Signaling Reveal Untapped Targets for Cancer Therapy

  2021cites this paper
• Antidepressants Promote and Prevent Cancers

  2020cites this paper
• The role of platelet parameters in thrombosed hemorrhoids

  2020cites this paper
• Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice.

  2019cites this paper
• A polyphenol-rich diet is associated with decreased platelet aggregation in breast cancer patients

  2019cites this paper
• Tumor-educated platelets.

  2019cites this paper
• The role of coagulation and platelets in colon cancer-associated thrombosis.

  2019cites this paper
• Mechanisms of receptor shedding in platelets.

  2018cites this paper
• Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug

  2018cites this paper
• Platelet activation and antiplatelet therapy in sepsis: A narrative review.

  2018cites this paper
• Journal of Coloproctology

  year unknowncites this paper